**Author Information** An event is serious (based on the ICH definition) when the patient outcome is:\* death\* life-threatening\* hospitalisation\* disability\* congenital anomaly\* other medically important event

A 33-year-old man developed fatal Middle East respiratory syndrome-coronavirus (MERS-CoV) infection, which lead to acute kidney injury (AKI), myositis, hypoxaemia and refractory shock following chemotherapy with methotrexate, ifosfamide, etoposide, prednisolone and asparaginase \[L-asparginase\], and unspecified chemotherapy \[*routes, dosages and time to reactions onsets not stated*\].

The man was diagnosed with primary cutaneous T-cell lymphoma on the face, scalp, trunk and lower and upper limbs in June 2014. He received unspecified chemotherapy and radiotherapy. On 18 May 2015, his chemotherapy was switched to another unspecified chemotherapy due to lack of complete remission with the initial chemotherapy. On 29 July 2015, he was hospitalised to receive IV antibiotic therapy for sepsis and cellulitis. On day 12 of the hospitalisation, he started receiving chemotherapy according to the SMILE protocol, which comprised of methotrexate, etoposide, ifosfamide, asparaginase and prednisolone. He subsequently developed thrombocytopenia and neutropenia.

The man\'s chemotherapy was later discontinued. On day 21, he had a fever and productive cough, with new chest infiltrates. He was treated considering it as a possible healthcare-associated pneumonia. On day 23, a sputum culture showed presence of *Acinetobacter Baumannii* and *Klebsiella Pneumoniae*, however, sputum MERS-CoV real-time reverse transcription PCR (rRT-PCR) was negative. On day 42, positive results for sputum MERS-CoV rRT-PCR were noted. On day 43, he was transferred to ICU due to increasing hypoxaemia, and was intubated along with mechanical ventilation. A subsequent chest radiography revealed bilateral infiltrates. He was treated with an unspecified neuromuscular blockade and lung-protective ventilation strategy. A MERS-CoV rRT-PCR from tracheal aspirates was persistently positive until his death. Subsequent kidney function tests revealed mild impairment with increased serum creatinine. On day 50, he died due to severe hypoxaemia and refractory shock. An autopsy was performed, which revealed acute kidney injury and myositis, on light microscopy. Further, histochemical and immuno-histochemical study of lung, kidney and skeletal muscles were suggestive of pulmonary and extra-pulmonary MERS-CoV infection, which were attributed to his immunosuppressed state due to the chemotherapy.

**Author comment:** *\"It is possible that our patient\'s reaction to MERS-CoV infection was atypical owing to his immunosuppressive status due to his primary disease (lymphoma) and chemotherapy.\" \"MERS-CoV infection can be asymptomatic or causes disease that ranges from transient, self-limited common cold to severe acute hypoxemic respiratory failure with a high case fatality rate.\" \"Extra pulmonary organs dysfunction commonly occurs in MERS-CoV patients, particularly acute renal failure\".*
